News

OCRA’s Statement on the Introduction of HR 4412 to Reauthorize Johanna’s Law

Your Representative needs to hear from YOU…

Read on

Does Ovarian Cancer Stop Periods?

No, ovarian cancer does not stop your period in and of itself. It is still possible to menstruate with the presence of the disease in your body…

Read on

Oral Contraceptives Associated with Lower Ovarian Cancer Risk in BRCA Mutation Carriers

A study published in the American Journal of Obstetrics & Gynecology provides new insight into previously established research that oral contraceptive use is connected to lower ovarian cancer risk in the general population, by more closely…

Read on

Retiform Sertoli-Leydig Cell Ovarian Cancer | Janice’s #RareAware Story

Janice lives in NW Pennsylvania, and was diagnosed in 1997, at age 34, with stage II retiform sertoli-leydig cell ovarian cancer with mucinous heterologous elements…

Read on

Granulosa Cell Tumor | Sally’s #RareAware Story

Sally lives in Mechanicsville, VA, and was diagnosed with a granulosa cell tumor…

Read on

Small Cell Carcinoma of the Ovary, Hypercalcemic Type | Anne’s #RareAware Story

Anne lives in Morton, PA, and was diagnosed with small cell carcinoma of the ovary, hypercalcemic type…

Read on

Granulosa Cell Tumor | Karien’s #RareAware Story

Karien lives in Kingaroy, Queensland, Australia and was diagnosed with a granulosa cell tumor. What has been your frustration in having a rare form of ovarian cancer? No doctors or surgeons knowing of my diagnosis, no research into it…

Read on

Granulosa Cell Tumor | Christine’s #RareAware Story

Christine lives in Atlanta, GA, and was diagnosed with a granulosa cell tumor…

Read on

Adult Granulosa Cell Tumor | Fortuna’s #RareAware Story

Fortuna lives in Naples, Italy, and has adult granulosa cell cancer…

Read on

OCRA-Funded Study Identifies Antibiotic Found to Kill Tumor Cells Containing BRCA Mutations

A long-running study from Dana-Farber Cancer Institute, published in Nature Cancer and co-funded by OCRA, has discovered that the antibiotic novobiocin is capable of targeting and killing tumor cells in laboratory cell lines and tumor models with…

Read on

Racing to Cure Ovarian Cancer | Heroes Highlights

As our community continues to come together to make strides against ovarian cancer, we want to give a shout-out to our many OCRA Heroes who push themselves physically, creatively or in myriad other ways to raise money for research…

Read on

OCRA’s Woman to Woman Program Touted in Qualitative Study

Researchers from the University of Kansas School of Medicine conducted a study to capture the value and experience of giving and receiving peer support in the face of a gynecologic cancer diagnosis by interviewing Woman to Woman mentors…

Read on